BICYCLE THERAPEUTICS PLC (BCYC)
↓ Download CSV- Sector Manufacturing
- Incorporated X0
- Fiscal year ends Dec 31
In fiscal 2025, BICYCLE THERAPEUTICS PLC reported revenue of $72.59M, up 105.8% from the prior year. The company ran a net loss, with a net margin of -301.7%. It held $717.60M in total assets against $107.62M in total liabilities.
Key ratios (FY2025)
-340.4%
Operating margin
-301.7%
Net margin
-35.9%
Return on equity
+105.8%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.59M | $35.27M | $26.98M | $14.46M | $11.70M | $10.39M | $13.80M | $7.14M | $2.06M | — |
| Operating Income | -$247.06M | -$209.87M | -$189.95M | -$116.65M | -$65.62M | -$51.96M | -$26.30M | -$21.75M | -$16.21M | — |
| Net Income | -$218.96M | -$169.03M | -$180.66M | -$112.72M | -$66.82M | -$51.01M | -$30.61M | -$21.85M | -$16.26M | — |
| EPS (Diluted) | $-3.16 | $-2.90 | $-5.08 | $-3.80 | $-2.67 | $-2.66 | $-2.77 | — | — | — |
| Total Assets | $717.60M | $956.87M | $595.34M | $410.61M | $479.79M | $161.15M | $110.19M | $81.63M | — | — |
| Total Liabilities | $107.62M | $163.81M | $224.41M | $139.83M | $133.54M | $65.69M | $17.00M | $29.25M | — | — |
| Shareholders' Equity | $609.98M | $793.06M | $370.93M | $270.78M | $346.25M | $95.46M | $93.20M | -$69.83M | -$47.18M | -$33.80M |
| Cash & Equivalents | $628.11M | $879.52M | $526.42M | $339.15M | $438.68M | $0 | $0 | $0 | — | — |
| Operating Cash Flow | -$249.68M | -$164.72M | -$60.63M | -$86.11M | -$14.79M | -$17.79M | -$28.61M | -$26.08M | -$1.42M | — |
| Capital Expenditures | $2.35M | $1.24M | $2.93M | $18.99M | $2.03M | $1.20M | $1.55M | $1.19M | $1.11M | — |
| Shares Outstanding | 69.37M | 69.06M | 42.43M | 29.87M | 29.58M | 21.09M | 17.99M | 814.7K | — | — |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |